About Corden Pharma
Corden Pharma is a company based in Plankstadt (Germany) founded in 2006 was acquired by International Chemical Investors in February 2013. Corden Pharma has completed 2 acquisitions, including AmbioPharm and Ancora Pharmaceuticals. Corden Pharma offers products and services including APIs, Drug Products, and Lipid Excipients. Corden Pharma operates in a competitive market with competitors including Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
- Headquarter Plankstadt, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
AmbioPharm
& 1 more
-
Acquired by
International Chemical Investors
(Feb 13, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Corden Pharma
Corden Pharma offers a comprehensive portfolio of products and services, including APIs, Drug Products, and Lipid Excipients.
Development and manufacturing of drug substances for pharmaceuticals
Production of sterile and non-sterile forms for drug delivery
Creation of lipid-based products for pharmaceutical formulations
People of Corden Pharma
Unlock access to complete
Software Development Team
28 people
Product Management Team
14 people
Sales and Marketing
13 people
Finance and Accounting
9 people
Leadership Team
8 people
Head Team
6 people
Legal and Compliance
6 people
Operations Team
6 people
Unlock access to complete
Funding Insights of Corden Pharma
Detailed funding history for Corden Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Corden Pharma
Corden Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include International Chemical Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A privately owned industrial group focused on chemical investments.
|
Locked | Locked | Locked |
Investor details for Corden Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Corden Pharma
Corden Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include AmbioPharm and Ancora Pharmaceuticals.
Investment portfolio details for Corden Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CDMO and analytical services for peptide development are provided.
|
Locked | Locked | 2006 | Locked | |
|
Vaccines for hospital-acquired infections are developed in preclinical stages.
|
Locked | Locked | 2002 | Locked |
Complete acquisition details for Corden Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Corden Pharma
Detailed financials for Corden Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Corden Pharma Comparisons
Peer comparison for Corden Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Corden Pharma
Corden Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Asymchem, Seqens, Aurobindo Pharma and Aptuit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
|
| Locked | Locked | Locked |
Contract manufacturing services for small molecules and peptides are provided.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
Contract research and development services for small molecules are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
Detailed competitors of Corden Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Corden Pharma
Complete news archive for Corden Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Corden Pharma
Corden Pharma was founded in 2006.
Corden Pharma is headquartered in Plankstadt, Germany. It is registered at Plankstadt, Baden-wurttemberg, Germany.
CordenPharma is a full-service partner in the Contract Development and Manufacturing (CDMO) of APIs, Drug Products and associated Packaging, Logistics, and Clinical Supply Services. Through their network of fully-inspected cGMP facilities across Europe and the US which are organised under six technology platforms namely, Antibiotics, Highly Potent Oncology Products, Small Molecules, PeptidesLipids Carbohydrates, Injectables, Fermentation Enzymes they offer product development and manufacturing services. The company has facilities in Italy, US, Germany, France, Belgium and Switzerland. CordenPharma claims that it can translate complex ideas at any stage of development into high-value products. CordenPharma specialises in the development of oncology drugs(Sterile and Oral dosage forms, including HPAPIs) and fermentation based small molecules.
Corden Pharma's top competitors include Concord Biotech, Almac Group and Indoco Remedies.
Corden Pharma offers APIs, Drug Products, and Lipid Excipients.
Corden Pharma has made 2 acquisitions, including AmbioPharm, and Ancora Pharmaceuticals.
Corden Pharma has 1 investor. Key investors include International Chemical Investors.